OBJECTIVE To analyze the risk factors for severe adenovirus pneumonia(AP)in children and construct a nomogram.METHODS A total of 108 children with AP admitted to the Department of Infectious Diseases at Children's Hospital of Nanjing Medical University from Nov.2023 to Apr.2024 were selected and divided into a severe group(n=38)and a non-severe group(n=70)based on disease severity.Logistic regression analysis was used to identify the risk factors for severe AP in children.A nomogram was developed by R software,and its per-formance was evaluated by the receiver operating characteristic(ROC)curve,calibration curve and Hosmer-Lemeshow goodness-of-fit test.RESULTS Anemia(OR=4.370,95％CI:1.370-13.941,P=0.013),congenital heart disease(OR=4.036,95％CI:1.277-12.754,P=0.017),multiple infection(OR=4.984,95％CI:1.546-16.069,P=0.007)and pulmonary consolidation(OR=17.492,95％CI:5.288-57.864,P＜0.001)were identified as risk factors for severe AP in children.The area under the ROC curve of the nomogram for pre-dicting severe AP in children was 0.896(95％CI:0.838-0.954).The slope of calibration curve was close to 1,and the Hosmer-Lemeshow goodness-of-fit test yielded x2=7.754,P=0.355.CONCLUSIONS Anemia,congenital heart dis-ease,multiple infection and pulmonary consolidation are risk factors for severe AP in children.The constructed nomogram enables individualized prediction of severe AP risk in children,thereby guiding personalized interventions.

OBJECTIVE To analyze the risk factors for severe adenovirus pneumonia(AP)in children and construct a nomogram.METHODS A total of 108 children with AP admitted to the Department of Infectious Diseases at Children's Hospital of Nanjing Medical University from Nov.2023 to Apr.2024 were selected and divided into a severe group(n=38)and a non-severe group(n=70)based on disease severity.Logistic regression analysis was used to identify the risk factors for severe AP in children.A nomogram was developed by R software,and its per-formance was evaluated by the receiver operating characteristic(ROC)curve,calibration curve and Hosmer-Lemeshow goodness-of-fit test.RESULTS Anemia(OR=4.370,95％CI:1.370-13.941,P=0.013),congenital heart disease(OR=4.036,95％CI:1.277-12.754,P=0.017),multiple infection(OR=4.984,95％CI:1.546-16.069,P=0.007)and pulmonary consolidation(OR=17.492,95％CI:5.288-57.864,P＜0.001)were identified as risk factors for severe AP in children.The area under the ROC curve of the nomogram for pre-dicting severe AP in children was 0.896(95％CI:0.838-0.954).The slope of calibration curve was close to 1,and the Hosmer-Lemeshow goodness-of-fit test yielded x2=7.754,P=0.355.CONCLUSIONS Anemia,congenital heart dis-ease,multiple infection and pulmonary consolidation are risk factors for severe AP in children.The constructed nomogram enables individualized prediction of severe AP risk in children,thereby guiding personalized interventions.

Oxidative stress injury and mitochondrial dysfunction are major obstacles to neurological functional recovery after ischemic stroke. The development of new approaches to simultaneously diminish oxidative stress and resist mitochondrial dysfunction is urgently needed. Inspired by the overproduced reactive oxygen species (ROS) at ischemic neuron mitochondria, multifunctional nanoparticles with ROS-responsiveness and mitochondrial-targeted (SPNPs) were engineered, achieving specific targeting delivery and controllable drug release at ischemic penumbra. Due to the nose-to-brain pathway, SPNPs which were encapsulated in a thermo-sensitive gel by intranasal administration were directly delivered to the ischemic penumbra bypassing the blood‒brain barrier (BBB) and enhancing delivery efficiency. The potential of SPNPs for ischemic stroke treatment was systematically evaluated in vitro and in rat models of middle cerebral artery occlusion (MCAO). Results demonstrated the mitochondrial-targeted and protective effects of SPNPs on H₂O₂-induced oxidative damage in SH-SY5Y cells. In vivo distribution analyzed by fluorescence imaging proved the rapid and enhanced active targeting of SPNPs to the ischemic area in MCAO rats. SPNPs by intranasal administration exhibited superior therapeutic efficacy by alleviating oxidative stress, diminishing inflammation, repairing mitochondrial function, and decreasing apoptosis. This strategy provided a multifunctional delivery system for the effective treatment of ischemic injury, which also implies a potential application prospect for other central nervous diseases.